HOT will be next. After Amgen paid $550 million for Neo there's no way a BP won't gobble HOT up. In fact, it's interesting that Amgen didn't license both. I imagine Doc wanted to keep HOT in the bank at that point.

Joche, welcome back. I remember you from the YMB and always appreciated your views on both the science issues and the investment issues. It's pretty ridiculous that the pps is now a lot lower than it was during the Pearson libel attack more than two years ago, given the major progress that's been made. Recall that that attack was stopped by Feuerstein's report and then Adage buying more shares at 7.50. Wouldn't surprise me if the same crooks are behind this more recent attack, sans the fraudulent article by Pearson. Then the run to 30 began.

Fair enough, Cyclist.

Fbg, I think it very obvious that DOC is feeling pressure from this. I am sure he has received quite a few calls from investors, ranging from fund managers to his own friends and relatives. In my view, the only step he could really take that might improve the pps is a money deal for licensing. If he is reluctant to license AXAL EU, surely there is a market for other platforms, such as HOT. I do not have the information or the ability required to calculate the cost-benefits of licensing now vs. future dilution, but it would seem to me that selling off equity in the enterprise as a whole is probably more "expensive" long term than selling off partial equity in specific products/indications through licensing. In my opinion, he should get this done, and de-risk now. And I believe that he will, whether for AXAL or for a combo or HOT.

True. As a general rule, though, maximizing long term shareholder value is the goal. Value is, after all, based on discounted projected future net cash flow. Obviously, opinions vary as to how to maximize it. In ADXS's case, that largely comes down to-- aside from getting to market which is obvious--whether to sell equity in the enterprise (i.e., capital raising) vs. selling equity in the individual products (i.e., licensing).

Fbg, it's "possible" that the takedown was prompted by an infinite list of issues; not all of them make sense. Tutes are not going to go to all of that effort, and reduce the value of their own investment, over the management compensation plan. Although if the board starts actually granting too many bonus shares under the plan you should be happy, because the tutes might then start grabbing some board seats. I don't think it will happen. Far more likely that tutes might take issue with DOC's lack of/refusal to do monetary licensing deals to raise cash. Although that is unlikely as well. Attacking your own stock, while it does occur, is a rarity. Considering the manipulation that has been going on for two years, wouldn't you find it more likely that it is the same parties that did this one as opposed to ADXS's own investors tanking their own shares on purpose? I mean, seriously.

Dew, would you care to share your institutional investors' view of these recent developments? You've said that they don't care for the Kathy Ireland piece, but what else are they saying? And what is your view?

That is true. But even a friendly bid would be acceptable to me, not because it would be accepted but because of the implications.

A hostile takeover bid at 12 would be fantastic. It would result in nothing other than a big stock runup. And they always accumulate shares before announcing it. But it ain't gonna happen because they know it's a waste of time.

Especially those with patience and money to buy more at this price.

Gantor nails it. And the reason that they tried to avoid triggering the uptick rule as long as possible is to make the attack last several days instead of all at once, in order to ensure that the margin calls "stuck" so they could get those shares. Compare to the orchestrated "flash crash" in September 2015, which quickly rebounded significantly due to the uptick rule being implemented immediately, and people figuring out quickly what they were doing. That attack one was on the heels of GOOD news, i.e., the excellent GOG Phase II interim data. Goes to show that if they put enough effort into it and coordinate it properly, a takedown does not need to be based on anything. In fact, it can be done even on good news. It is all about manipulative trading, not substance or reality. Some people here should accept this point, because it it the truth.

It is not clear when she said "revenue vs. capital markets" whether she meant revenue from actual vaccine sales or revenue from upfront cash in licensing deals. I believe she meant the first one, not the second.

If you look at the daily chart you could place a ruler across 5.92 for most of the day. That does not occur in the natural world. SO obvious. They capped it. Anyone who doesn't recognize this for algo manipulation is clueless.

You have a point, Hov. A pr about plans to apply might be a bit much. But I wonder if they will even pr the actual application.

Hovacre often provides information to the investing public that ADXS should be providing. For example, potential investors who are not already following the company would have no clue that ADXS is going for EMA approval.

Good job, Hovacre!

There are no $6 strike options. But this whole thing was probably started, in part, in order to burn the 1700 June 7.50 calls.

The warrant premium has increased app. 75% this week. And they are harvesting lots of them today through margin selling, yet the bid doesn't budge. Previous days this week it was mainly buying, even at the inflated premium.

The big fish all work together. I've never trusted Fidelity. We are seeing alot of forced margin sales today. It is one reason why they prolong these takedowns sometimes. If they recover too quickly it lets the margined investor off the hook.

Hey, Bomba. I don't totally discount the possibility of a large shareholder causeing this takedown as retaliation, and a message to management. However, there is now way that the retaliation is for the paltry bonus shares issued to management. If anything, I would see it as a message that they want monetary deals with BPs NOW, no more future dilution. That being said, I don't think this has anything to do with retaliation. It's just a short share grab. Just my opinion. Good to see you, my friend.

Dawson, the crooks did the same thing to ADXS in Sept. 2015 when they caused an HFT flash crash within sixty seconds of ADXS releasing excellent GOG results. Before people could even digest the PR, which everyone was waiting for, they crashed the stock like $8 on millions of shares in volume.

My take on the reason for the takedown: some large shorts will not be comfortable holding with the EMA application pending, because approval would be a disaster for them. They were not shaking enough shares loose just keeping it trapped in the prior range. If they weren't getting shares in that range, they certainly are not getting them once the EMA application is filed, as early as October 1. So they decided to take this early opportunity for a share grab while they can, using the fake news related to Astra as the excuse. In addition to the hedgie shorts, the players probably include the mm's, who are/were almost certainly very net short, and probably some of the tute longs themselves, who shorted their own shares and may want to get back in before the EMA process starts. The prospect of a major licensing deal for the EU also looms, as discussed at the conference.

Wellness, I doubt that short volume website has accurate info. But, if anything, it understates the daily short volume. Nobody false reports a short sale but they routinely do not report them.

Smart, Mck. You are one of the few that gets it. Roughly 18 million shares are owned by retail and this is a concerted effort to get them. The manner in which it is occurring gives it away. Tutes don't just dump their shares all at once; they are not idiots. For example, when T Rowe--one of the few major tutes holders who have sold--got rid of 1.5 million shares nobody even noticed until it was reported in the quarterly filings. Moreover, there has been no development that would cause tutes to reevaluate and sell. They are not stupid enough to fall for the "fake news" that the manipulators sell to retail. This is way overdone. It's a big fake out.

There used to be a site called shortanalytics but it was shut down a couple of months ago. I personally don't believe there is any reliable source for that info on a daily basis, although people claim that there is. And I believe that the mm's shorting does not show up in any data, even the official data release bi-monthly, because they do not need to actually borrow shares. Then, of course, you have illegal naked shorting, which I believe is rampant in ADXS, although they do it in short trading cycles to avoid creating a trail. As long as they buy back and deliver the shares within a certain number of days it is not reported.

This shakeout and decline is too obvious. Even if big tutes were selling millions of shares they would not do it in such a linear fashion without regard to he effect on the share price. The traders would "work it" on their behalf to get the best prices possible, not just engage in a straight dump like a trading orangutan. The relative lack of pauses in the slide shows that the trading is designed for maximum impact, both psychologically and upon the decline in the share price. Smart traders who are looking to sell do not try their hardest to cause the stock to decline as much as possible in the process. They do the opposite, to get the best prices. This is all a Viagra version of the usual b.s. manipulation.

Everybody read this post. Gantor is 100% correct. A majority of people do not understand the mechanics of trading, how market making really works, how HFT works and how manipulation is accomplished. So they cannot recognize it. This is ALL, for many months now, an obvious, coordinated and well-planned short/suppression scheme by a number of powerful entities, including the mm's, hedge funds and even the tute longs. Aside from the shorting ahead of the baseless FDA hold, there is no valid underlying basis for any of this. They do it because they can. Period.

Gantor, no doubt that this is an unusually strong move/takedown. Although the slide during the biotech crash in February 2016 and the orchestrated flash crash in September 2015 were worse, if I recall.

Your statement is incorrect, fraud fighter. First of all, Astra's trials are still ongoing. Second, just because people here predicted that Astra would be the AXAL partner doesn't mean it is a shocker that they haven't. Third, there may have been discussions with Astra and the parties could not agree to terms, simple as that. Finally, there are many possible reasons for no further partnership other than a baseless conclusion that the Astra trials are going badly. In fact, we don't even really know that Astra is out of the game, other than conjecture based upon it absence from a chart in the presentation.

Don't know him and don't even particularly care for him. And it is not someone big getting out. It is a concerted effort to manipulate, with many daytraders and other bandwagon riders playing the momentum, fueled by stop losses, margin calls, and weak hands folding.

That is the intent of it.

Exactly, CATT. Pure manipulation. What tute is going to hold through all of the months of manipulation, the baseless FDA hold, etc. and then sell just as the company is planning EMA approval? Remind me not to put money into that imaginary fund.

Really? Then why are people blaming the investor presentation for a large stock slide?

If somebody could point me to a single plausible, fundamental basis for this slide I would be open to considering it. Nobody has done so. So my view does not change. I have high confidence in my beliefs and do not get dissuaded from them by baseless, emotional rationalizations.

Taking out stops, forcing margin calls and scaring the weak. That's what it is all about. There was zero in the Investor presentation that would cause any rational fund manager to change his/her view and suddenly decide to dump, in a very inefficient manner to boot. They would run it up or do it in steps at least. They are not that stupid to just unload linearly.

This IS Dan's fault. The market suddenly realized that Dan received a 134k share bonus a couple of months ago. So they are all getting out now, due to the "misalignment of interests." Also, that horrible Investor Day presentation, which revealed abysmal trial data, no plan for EU approval, and no intent to commercialize the EU with a partnership agreement. No wonder the tutes are bailing out in droves. This company is doomed!

Just bought a sizable batch of shares. It's a gift. I wish everybody else would sell so the shorts can cover and we can get this over with. Just kidding. I wish all longs here well.

Amen to that. There is pleasure on some level when the stock slides by those who want to be proven correct about their incorrect reasons for it.

Yep. Even the people who intend to hold for the big payday sweat the interim antics. What they should be doing is buying. It's a gift.

Very possible. And that is a huge time and money saver. With a better checkpoint and, in my view, a better partner. Astra is out to lunch betting on INO, albeit for a different indication.